The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,529,685 in first-year total cost, median $191,106.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-R (J1)]7
- Special Emphasis Panel[ZCA1 RTRB-R (M1)]1
Most frequent institutions
- UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH2
- OHIO STATE UNIVERSITY1
- UNIVERSITY OF CHICAGO1
- UNIVERSITY OF MIAMI SCHOOL OF MEDICINE1
- UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Determining immune-mediated mechanisms of beneficial bacteria in colon cancer1K22CA289144-01A1 | WEIS, ALLISON | UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH, UT | $201,960 | ZCA1 |
| 2025 | Modeling Enhancer Hijacking in Cancer via Genome Engineering and Single-Cell Sequencing1K22CA293300-01A1 | XU, ZHICHAO | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $194,914 | ZCA1 |
| 2025 | A novel approach for the use of normal colon organoids in the identification of true casual variants and mechanistic interrogation of their gene targets in colon cancer risk1K22CA297064-01A1 | DEVALL, MATTHEW A.M | UNIVERSITY OF VIRGINIA, VA | $192,888 | ZCA1 |
| 2025 | Simultaneously Targeting Lineage Plasticity and Therapy Resistance Drivers Using a Novel Dual-PROTAC Strategy1K22CA299598-01 | DENG, SU | YALE UNIVERSITY, CT | $192,564 | ZCA1 |
| 2025 | Elucidating Mechanisms of Mitochondrial Biogenesis in T Cell Immunity1K22CA292575-01A1 | KURMI, KIRAN | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $189,648 | ZCA1 |
| 2025 | Mutation specific pan-KRAS inhibitor signaling responses and anti-tumor effect1K22CA292325-01A1 | KIM, DONGSUNG | OHIO STATE UNIVERSITY, OH | $188,351 | ZCA1 |
| 2025 | Targeting Glycerol Metabolism in anti-Tumor Immunity1K22CA296237-01A1 | YAO, CONGHUI | UNIVERSITY OF CHICAGO, IL | $185,760 | ZCA1 |
| 2025 | Reprogramming myeloid cells by JAK inhibition to enhance checkpoint blockade therapy1K22CA292568-01A1 | ZAK, JAROSLAV | UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH, UT | $183,600 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.